Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Tata Nifty Midcap 150 Momentum 50 Index Fund | Axis Nifty500 Low Volatility 50 Index Fund | |
|---|---|---|
| Category | Index Funds (Equity) | Index Funds (Equity) |
| Plan | Regular | Regular |
| Fund house | Tata | Axis |
| AUM | ₹1,228 Cr | ₹1 Cr |
| NAV | ₹17.9500 | ₹10.7491 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | — | 2 months |
| Expense ratio | 1.3% | 2.7% |
| Stars | Not rated | Not rated |
| Growth Score | — | — |
AUM: AMFI's average assets under management for July - September 2026, in ₹ crore, for the whole fund (Direct and Regular, Growth and IDCW added up). The same source and period for every fund, so the figures compare.
Returns
| Tata Nifty Midcap 150 Momentum 50 Index Fund | Axis Nifty500 Low Volatility 50 Index Fund | |
|---|---|---|
| 1 month | — | +8.80% |
| 3 months | — | — |
| 6 months | — | — |
| YTD | — | — |
| 1 year | — | — |
| 3 years (CAGR) | — | — |
| 5 years (CAGR) | — | — |
| 10 years (CAGR) | — | — |
| Since launch | — | +9.85% |
Risk
| Tata Nifty Midcap 150 Momentum 50 Index Fund | Axis Nifty500 Low Volatility 50 Index Fund | |
|---|---|---|
| Volatility | — | — |
| Downside volatility | — | — |
| Sharpe | — | — |
| Sortino | — | — |
| Calmar | — | — |
| Return / risk | — | — |
| Deepest fall | — | −2.57% |
| Days to recover | — | 7 |
| Below its high | — | 0.00% |
Against benchmark
| Tata Nifty Midcap 150 Momentum 50 Index Fund | Axis Nifty500 Low Volatility 50 Index Fund | |
|---|---|---|
| Alpha | — | — |
| Beta | — | — |
| R² | — | — |
| Up capture | — | — |
| Down capture | — | — |
| Tracking error | — | — |
| Information ratio | — | — |
| Treynor | — | — |
Consistency
| Tata Nifty Midcap 150 Momentum 50 Index Fund | Axis Nifty500 Low Volatility 50 Index Fund | |
|---|---|---|
| Best 1-year | — | — |
| Middle 1-year | — | — |
| Worst 1-year | — | — |
| 1-year periods with a loss | — | — |
| Middle 3-year | — | — |
| Positive months | — | — |
| Best day | — | +1.52% |
| Worst day | — | −1.77% |
| Worst 5% day | — | −0.77% |
| Positive days | — | 65.6% |
| NAVs a year | — | 33 |
SIP of ₹10,000 a month
| Tata Nifty Midcap 150 Momentum 50 Index Fund | Axis Nifty500 Low Volatility 50 Index Fund | |
|---|---|---|
| 5-year XIRR | — | — |
| 5-year value | — | — |
| 3-year XIRR | — | — |
| 1-year XIRR | — | — |
Holdings overlap i
| Tata Nifty Midcap 150 Momentum 50 Index Fund | Axis Nifty500 Low Volatility 50 Index Fund | |
|---|---|---|
| Tata Nifty Midcap 150 Momentum 50 Index Fund Regular · filing Oct 2026 | — | 7% |
| Axis Nifty500 Low Volatility 50 Index Fund Regular · filing Oct 2026 | 7% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Tata Nifty Midcap 150 Momentum 50 Index Fund and Axis Nifty500 Low Volatility 50 Index Fund
Overlap
7.1%
smaller weight of each shared stock, added up
Stocks in common
4
of 50 and 50
Weight in common
11% · 7%
of each fund's money
Filings compared
Oct 2026 · Oct 2026
same month
| Common stock | Tata Nifty Midcap 150 Momentum 50 Index Fund | Axis Nifty500 Low Volatility 50 Index Fund | Counts toward overlap |
|---|---|---|---|
| The Federal Bank Limited | 5.04% | 2.23% | 2.23% |
| Marico Limited | 2.31% | 2.16% | 2.16% |
| Lupin Limited | 2.23% | 1.91% | 1.91% |
| Max Financial Services Limited | 0.99% | 0.77% | 0.77% |
| 4 stocks | 10.6% | 7.1% | 7.1% |
Only in Tata Nifty Midcap 150 Momentum 50 Index Fund (46)
| Laurus Labs Limited | 8.73% |
| Multi Commodity Exchange of India Limited | 5.92% |
| BSE Limited | 4.76% |
| Bharat Heavy Electricals Limited | 4.25% |
| Ge Vernova T&D India Limited | 4.20% |
| Bharat Forge Limited | 3.57% |
| Hitachi Energy India Limited | 3.21% |
| National Aluminium Co Limited | 3.03% |
| Polycab India Limited | 3.01% |
| Aurobindo Pharma Limited | 2.42% |
| AU Small Finance Bank Limited | 2.34% |
| Vodafone Idea Limited | 2.31% |
| Glenmark Pharmaceuticals Limited | 2.16% |
| IndusInd Bank Limited | 2.03% |
| Indus Towers Limited | 2.02% |
| Steel Authority of India Limited | 1.87% |
| One 97 Communications Limited | 1.86% |
| FSN E-Commerce Ventures Limited | 1.85% |
| Apar Industries Limited | 1.75% |
| Fortis Healthcare Limited | 1.73% |
| Aditya Birla Capital Limited | 1.64% |
| Ashok Leyland Limited | 1.56% |
| JSW Energy Limited | 1.56% |
| Radico Khaitan Limited | 1.54% |
| Lloyds Metals And Energy Limited | 1.52% |
and 21 smaller holdings (18.6% of the fund).
Only in Axis Nifty500 Low Volatility 50 Index Fund (46)
| Tata Consultancy Services Limited | 6.08% |
| Bharti Airtel Limited | 5.45% |
| State Bank of India | 5.06% |
| Sun Pharmaceutical Industries Limited | 4.89% |
| NTPC Limited | 4.86% |
| Power Grid Corporation of India Limited | 4.65% |
| Divi's Laboratories Limited | 4.12% |
| UltraTech Cement Limited | 4.08% |
| Maruti Suzuki India Limited | 3.98% |
| Bajaj Auto Limited | 3.70% |
| Apollo Hospitals Enterprise Limited | 3.66% |
| Asian Paints Limited | 2.91% |
| Coal India Limited | 2.91% |
| Cipla Limited | 2.73% |
| Torrent Pharmaceuticals Limited | 2.65% |
| Oil & Natural Gas Corporation Limited | 2.64% |
| Dr. Reddy's Laboratories Limited | 2.56% |
| Tech Mahindra Limited | 2.36% |
| Tata Power Company Limited | 2.12% |
| Britannia Industries Limited | 2.11% |
| Eicher Motors Limited | 2.11% |
| TVS Motor Company Limited | 2.09% |
| HDFC Life Insurance Company Limited | 1.98% |
| Pidilite Industries Limited | 1.74% |
| ICICI Lombard General Insurance Company Limited | 1.35% |
and 21 smaller holdings (12.9% of the fund).
Method: from each fund's latest monthly portfolio filing, shares only (Indian and foreign equity; bonds, cash and derivatives are left out). Overlap adds up, for every stock both hold, the smaller of the two weights.
Sectors and company size
| Tata Nifty Midcap 150 Momentum 50 Index Fund | Axis Nifty500 Low Volatility 50 Index Fund | |
|---|---|---|
| Large companies | 20.7% | 83.1% |
| Mid companies | 79.3% | 18.4% |
| Small companies | — | 1.3% |
| Top 10 holdings | 45.7% | 46.9% |
| Largest sector | Pharmaceuticals & Biotechnology 17% | Pharmaceuticals & Biotechnology 20% |